Michael Egholm is President, Chief Executive Officer, and Director of Standard Biotools Inc. (LAB). The company reported total compensation of $8,823,502 for fiscal year 2025.
| Salary | $680,256 |
|---|---|
| Bonus | $0 |
| Stock awards | $5,337,883 |
| Option awards | $1,671,363 |
| Non-equity incentive plan | $1,120,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $8,823,502 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Standard Biotools Inc. filed April 27, 2026, accession 0001140361-26-017100.
| Peer-group chief executive median | $7,179,699 |
|---|---|
| Difference from that median | $1,643,803 |
| Percentile within the disclosed peer group | 68th |
| Peers with a disclosed figure | 19 |
Medians and percentiles are computed across the peer group Standard Biotools Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Egholm this page | President, Chief Executive Officer, and Director | $8,823,502 |
| Alex Kim | Chief Financial Officer | $4,005,165 |
| Sean Mackay | Chief Business Officer | $1,692,543 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Standard Biotools Inc. compensation brief.
Michael Egholm's compensation sits inside Standard Biotools Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.